Use of metabolic pathway flux information in anticancer drug design.

Ernst Schering Foundation symposium proceedings

Volumn , Issue 4, 2007, Pages 189-203

  Boros, L G ^a   Boros, T F ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; CELL PROLIFERATION; DRUG DESIGN; DRUG EFFECT; HUMAN; METABOLISM; NEOPLASM; OXIDATION REDUCTION REACTION; PATHOLOGY; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; DRUG DESIGN; HUMANS; NEOPLASMS; OXIDATION-REDUCTION; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 55949102650     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)